Injection 10 mg/mL, 40 mg/4 mL, 50 mg/5 mL
Consumer Medicine Information
What is in this leaflet
This leaflet answers some common questions about Navelbine® IV.
It does not contain all the available information.
It does not take the place of talking to your doctor or pharmacist.
All medicines have benefits and risks. Your doctor has weighed the risks of you being
given Navelbine® IV against the benefits this medicine is expected to have for you.
If you have any concerns about being given this medicine, ask your doctor or pharmacist.
Keep this leaflet.
You may need to read it again.
What Navelbine® lV is used for
Navelbine® IV is used to treat lung cancer and advanced breast cancer.
Navelbine® IV may be used on its own or in combination with other medicines to treat cancer.
Navelbine® IV belongs to a group of medicines called antineoplastic or cytotoxic medicines.
You may also hear of these medicines being called chemotherapy.
Navelbine® IV contains the medicine, vinorelbine which belongs to a family of medicines called
vinca alkaloids. Navelbine® IV works by stopping cancer cells from growing and multiplying causing the cells
Navelbine® IV is not recommended for use in children as there is no information on its effects
Your doctor may have prescribed Navelbine® IV for another purpose. Ask your doctor if you have any questions about why Navelbine® IV has been prescribed for you.
This medicine is available only with a doctor’s prescription.
Before you are given Navelbine® IV
When you must not be given it
Navelbine® IV should not be administered if you have an allergy to: the active substance, vinorelbine;
or to the other vinca alkaloids, (vinblastine, vincristine, vindesine, vinflunine);
or to any of the ingredients listed at the end of this leaflet.
Symptoms of an allergic reaction to Navelbine® IV may include:
shortness of breath
wheezing, difficulty breathing or a tight feeling in your chest
swelling of the face, lips, tongue or other parts of the body
rash, itching, hives or flushed, red skin.
dizziness or lightheadedness.
Navelbine® IV should not be administered if you have, or have had an infection or high temperature
in the last 2 weeks.
Your doctor may decide to delay your treatment until the infection has gone.
Navelbine® IV should not be administered if you have, or have had, any of the following medical
severe liver problems;
a reduced number of white blood cells (known as neutropenia) which you may notice
as frequent infections such as fever, severe chills, sore throat or mouth ulcers;
a reduced number of platelets (blood cells which help the blood to clot) which you
may notice as bleeding or bruising more easily than normal.
Navelbine® IV should not be administered if you have recently had a yellow fever vaccination
or plan to have one.
Navelbine® IV should not be administered if you are pregnant or intend to become pregnant.
Like most medicines used to treat cancer, Navelbine® IV is not recommended for use during pregnancy. Navelbine® IV may affect your developing baby if you take it during pregnancy. If there is a
need to consider Navelbine® IV during your pregnancy, your doctor will discuss with you the benefits and risks
of using it.
Do not breastfeed while being treated with Navelbine® IV.
Navelbine® IV may pass into breastmilk and therefore there is a possibility that the breast-fed
baby may be affected.
Navelbine® IV should not be administered after the expiry date printed on the pack. The expiry
date refers to the last day of that month.
If you have this medicine after the expiry date has passed, it may not work as well.
Navelbine® IV should not be administered if the packaging is torn or shows signs of tampering.
If it has expired or is damaged, return it to your pharmacist for disposal.
If you are not sure whether you should start having Navelbine® IV, talk to your doctor.
Before you are given it
Navelbine® IV is a potent cytotoxic drug that results in a decrease in blood cells. Your blood
count will be carefully monitored before and during your treatment.
Tell your doctor or pharmacist if you have allergies to:
any other medicines;
any other substances, such as foods, preservatives or dyes.
Tell your doctor if you have or have had any medical conditions, especially the following:
heart problems (including chest pain and heart attack);
a low white blood cell count which you may notice as signs of frequent infections
such as fever, severe chills, sore throat or mouth ulcers;
lung problems, including asthma;
Tell your doctor if you are having or have had any other medicines or treatments for
cancer, including radiation therapy.
Navelbine® lV must not be administered if you are currently receiving radiation therapy to your
Tell your doctor if you have recently had or plan to have a vaccination. Live attenuated
vaccines (eg. measles vaccine, mumps vaccine, rubella vaccine) are not recommended
while having Navelbine® IV.
Tell your doctor if you are pregnant or intend to become pregnant.
Navelbine® IV is not recommended for use in pregnancy.
If you are a fertile man or woman, you should use an effective method of contraception
during your treatment with Navelbine® IV and for three months after your last dose of Navelbine® IV.
Men being treated with Navelbine® IV are advised not to father a child during and up to a minimum of 3 months after
treatment. Prior to treatment, men are advised to seek advice on conserving sperm
due to the chance of irreversible fertility resulting from treatment with Navelbine® IV.
Tell your doctor if you are breast-feeding or plan to breast-feed.
You should not breast-feed while you are being treated with Navelbine® IV. Breastfeeding must be discontinued before starting treatment with Navelbine® IV.
Taking other medicines
Tell your doctor or pharmacist if you are taking any other medicines, including any
that you buy without a prescription from your pharmacy, supermarket or health food
Some medicines and Navelbine® IV may interfere with each other.
medicines used to prevent blood clots (anticoagulants) eg. phenindione, warfarin heparin;
phenytoin, a medicine used to treat epilepsy;
cyclosporin, tacrolimus, medicines which lower your immunity;
itraconazole and ketoconazole, medicines used to treat fungal infections;
mitomycin, lapatinib, medicines used to treat cancer;
medicines with known bone marrow toxicity (causing a reduced number of red or white
blood cells or platelets);
other medicines used to treat cancer such as cisplatin;
ritonavir, a medicine used to treat AIDS;
rifampicin, a medicine used to treat tuberculosis.
These medicines may be affected by Navelbine® IV or may affect how well it works. You may need to take different amounts of your
medicine, or you may need to take different medicines. Your doctor or pharmacist
will advise you.
Your doctor and pharmacist may have more information on medicines to be careful with
or to avoid while having Navelbine® IV.
If you have not told your doctor about any of the above, do so before you begin treatment
with Navelbine® IV.
How Navelbine® IV is given
How much is given
Your doctor will decide what dose you will receive. This depends on your body surface
area, your condition and factors such as your liver function and whether you are receiving
any other chemotherapy medicines.
Your doctor may adjust your dose during treatment.
Navelbine® IV may be given alone or in combination with other drugs.
Several courses of Navelbine® IV therapy may be needed depending on your response to treatment.
Navelbine® Oral reduces the number of white blood cells in the body. Your doctor will check
these levels regularly. Further doses of Navelbine® IV may be delayed until your blood cell numbers return to acceptable levels.
How it is given
Navelbine® IV is given as a slow injection into your veins, usually with an infusion (drip).
Navelbine® IV must only be given by a doctor or nurse.
How long it is given
Navelbine® IV is usually given every week, but it may be given less often if you are also having
other medicines to treat cancer. Your doctor will decide how many doses you will need.
If you miss a dose
Tell your doctor as soon as possible if you realise that you have missed an appointment
for receiving your dose of Navelbine® IV.
If you have problems remembering when your next dose is due, use a diary or calendar
or ask a friend to remind you.
As Navelbine® IV is given to you under the supervision of your doctor, it is very unlikely that
you will receive too much. However, if you experience any side effects while or after
being given Navelbine® IV, tell your doctor, nurse or pharmacist.
While you are being given Navelbine® IV
Things you must do
Tell your doctor or nurse immediately if you feel any pain or discomfort during the
Keep all appointments with your doctor.
Your doctor may want to do some blood and other tests from time to time to check on
your progress and monitor any unwanted side effects.
Keep follow up appointments with your doctor.
It is important to have your follow-up doses of Navelbine® IV at the appropriate times to get the best effects from your treatments.
Tell any other doctors, dentists and pharmacists who are treating you that you are
having treatment with Navelbine® IV.
If you are about to be started on any new medicine, tell your doctor, dentist or pharmacist
that you are having treatment with Navelbine® IV.
If you become pregnant while taking Navelbine® IV, tell your doctor immediately.
Navelbine® IV can lower the number of white blood cells and platelets in your blood. This means
that you have an increased chance of getting an infection or bleeding.
Take the following precautions to reduce your risk of infection or bleeding:
Check with your doctor immediately if you think you may be getting an infection, or
if you get a fever, chills, cough, hoarse throat, lower back or side pain or find
it painful or difficult to urinate;
Avoid people who have infections;
Be careful when using a toothbrush, toothpick or dental floss. Your doctor, dentist,
nurse or pharmacist may recommend other ways to clean your teeth and gums. Check
with your doctor before having any dental work.
Be careful not to cut yourself when you are using sharp objects such as a razor or
Avoid contact sports or other situations where you may bruise or get injured.
Things to be careful of
Be careful driving or operating machinery until you know how Navelbine® IV affects you.
If you experience symptoms that affect your ability to concentrate and react, do not
drive a car or operate machinery. Fatigue is a common side effect of Navelbine® IV. Make sure you know how Navelbine® IV affects you before you drive a car, operate machinery or do anything else that
could be dangerous if you are feeling tired. Drinking alcohol may make the tiredness
Tell your doctor, nurse or pharmacist as soon as possible if you do not feel well
while you are having Navelbine® IV.
Like other medicines that treat cancer, Navelbine® IV can cause side effects, some of which may be serious. You may need medical treatment
if you get some of these side effects.
Ask your doctor or pharmacist to answer any questions you may have.
Tell your doctor, nurse or pharmacist if you notice any of the following and they
unusual tiredness, weakness, sleepiness, drowsiness or lack of energy;
unusual hair loss or thinning;
aching muscles, muscle tenderness or weakness, not caused by exercise;
pain, including pain at the tumour site;
painful swollen joints;
These are the more common side effects of Navelbine® IV.
Tell your doctor or nurse as soon as possible if you notice any of the following:
frequent infections such as fever, severe chills, sore throat or mouth ulcers (symptoms
of a lack of white blood cells);
irritation, pain, swelling or colouring of the skin around the needle or along the
vein during the infusion;
numbness + tingling of fingers and toes;
weakness of legs or feet;
tiredness, headaches, being short of breath when exercising, dizziness and looking
pale (symptoms of a decreased number of red blood cells);
bleeding or bruising more easily than normal or nosebleeds (symptoms of a low blood
stomach pain with bloating, gut cramps and vomiting which may be symptoms of the small
bowel not working properly;
severe upper stomach pain;
pain or burning feeling when passing urine;
changes in your vision;
weakness, tiredness, loss of appetite, weight loss or stomach pain that may be symptoms
of liver disease.
These may be serious side effects. You may need medical attention.
If any of the following happen, tell your doctor or nurse immediately, or go to Accident
and Emergency at your nearest hospital:
difficulty breathing, short of breath;
breathlessness, which may be very severe and usually worse on lying down;
pain in bladder or back, blood in urine;
palpitations, fast or irregular heart beat;
rash, itching or hives on the skin;
swelling of the feet and ankles, face, lips, tongue or other parts of the body.
These are very serious side effects. You may need urgent medical attention or hospitalisation.
Other side effects not listed above may occur in some patients. Tell your doctor,
nurse or pharmacist if you notice anything else that is making you feel unwell.
Tell your doctor if you notice any of the side effects listed in this section, even
after you have finished your Navelbine® IV treatment.
The benefits and side effects of Navelbine® IV may take some time to occur.
Do not be alarmed by this list of possible side effects.
You may not experience any of them.
After treatment with Navelbine® IV
If you are storing Navelbine® IV at home:
Store Navelbine® IV in the refrigerator ( 2 to 8°C). Do not freeze it.
Protect Navelbine® IV from light.
Do not leave Navelbine® IV in the car.
Keep it where children cannot reach it.
If your doctor stops your treatment with Navelbine® IV, or it has passed its expiry date, return any leftover vials to your pharmacist.
Do not dispose of Navelbine® IV via wastewater or household waste. This will help to protect the environment.
What it looks like
Navelbine® IV is a clear, colourless to pale yellow solution. It comes in a clear glass vial
with a rubber stopper and royal blue cap. Each vial is packed in a carton.
water for injection
Navelbine® IV does not contain lactose, sucrose, gluten, tartrazine or any other azodyes.
Navelbine® IV is supplied by:
Pierre Fabre Australia Pty Limited
Suite 901, 1 Elizabeth Plaza
North Sydney NSW 2060
Australian Registration Number:
This leaflet was prepared in July, 2014 and updated in August, 2018.